Bradykinin Receptor B1 (BDKRB1) (C-Term) Peptide
Aperçu rapide pour Bradykinin Receptor B1 (BDKRB1) (C-Term) Peptide (ABIN8095628)
Antigène
Origine
Source
Application
-
-
Protein Region
- C-Term
-
Fonction
- BDKRB1 Peptide - C-terminal region
-
Séquence
- NFFAFTNSSL NPVIYVFVGR LFRTKVWELY KQCTPKSLAP ISSSHRKEIF
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti-BDKRB1 Antibody (ARP65156_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- BDKRB1 (Bradykinin Receptor B1 (BDKRB1))
-
Sujet
-
Background Information: Bradykinin, a 9 aa peptide, is generated in pathophysiologic conditions such as inflammation, trauma, burns, shock, and allergy. Two types of G-protein coupled receptors have been found which bind bradykinin and mediate responses to these pathophysiologic conditions. The protein encoded by this gene is one of these receptors and is synthesized de novo following tissue injury. Receptor binding leads to an increase in the cytosolic calcium ion concentration, ultimately resulting in chronic and acute inflammatory responses. Several transcript variants encoding different isoforms have been found for this gene.
Alternative Symbols: B1BKR, B1R, BKB1R, BKR1, BRADYB1
-
Poids moléculaire
- 40kDa
-
ID gène
- 623
-
NCBI Accession
- NP_000701
-
UniProt
- P46663
Antigène
-